Voya Investment Management LLC Sells 67,775 Shares of Cooper Companies Inc (COO)
Voya Investment Management LLC lowered its position in Cooper Companies Inc (NYSE:COO) by 74.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,458 shares of the medical device company’s stock after selling 67,775 shares during the quarter. Voya Investment Management LLC’s holdings in Cooper Companies were worth $5,523,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. increased its stake in shares of Cooper Companies by 4.2% in the second quarter. Sumitomo Life Insurance Co. now owns 5,143 shares of the medical device company’s stock valued at $1,211,000 after buying an additional 206 shares during the period. Bronfman E.L. Rothschild L.P. increased its stake in shares of Cooper Companies by 6.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,622 shares of the medical device company’s stock valued at $853,000 after buying an additional 232 shares during the period. Nomura Asset Management Co. Ltd. increased its stake in shares of Cooper Companies by 1.3% in the second quarter. Nomura Asset Management Co. Ltd. now owns 19,770 shares of the medical device company’s stock valued at $4,655,000 after buying an additional 262 shares during the period. Intrust Bank NA increased its stake in shares of Cooper Companies by 9.0% in the second quarter. Intrust Bank NA now owns 3,209 shares of the medical device company’s stock valued at $756,000 after buying an additional 265 shares during the period. Finally, Washington Capital Management Inc. increased its stake in shares of Cooper Companies by 16.2% in the second quarter. Washington Capital Management Inc. now owns 2,150 shares of the medical device company’s stock valued at $506,000 after buying an additional 300 shares during the period. 97.06% of the stock is owned by institutional investors.
In other news, SVP Agostino Ricupati sold 1,575 shares of the firm’s stock in a transaction on Thursday, September 6th. The stock was sold at an average price of $261.56, for a total transaction of $411,957.00. Following the completion of the sale, the senior vice president now directly owns 1,897 shares of the company’s stock, valued at approximately $496,179.32. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 2,147 shares of the firm’s stock in a transaction on Friday, June 29th. The shares were sold at an average price of $235.13, for a total value of $504,824.11. Following the sale, the chief operating officer now directly owns 28,395 shares of the company’s stock, valued at $6,676,516.35. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 80,575 shares of company stock valued at $20,392,174. Insiders own 1.60% of the company’s stock.
Shares of Cooper Companies stock opened at $272.84 on Wednesday. Cooper Companies Inc has a 1 year low of $216.47 and a 1 year high of $273.44. The firm has a market cap of $13.24 billion, a PE ratio of 23.84, a price-to-earnings-growth ratio of 2.16 and a beta of 0.67. The company has a quick ratio of 1.54, a current ratio of 2.58 and a debt-to-equity ratio of 0.70.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, August 30th. The medical device company reported $3.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.07 by ($0.07). Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%. The business had revenue of $660.00 million for the quarter, compared to analysts’ expectations of $653.44 million. equities analysts expect that Cooper Companies Inc will post 11.62 earnings per share for the current fiscal year.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Further Reading: Asset Allocation, Balancing Your Investments
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.